James Sidoti
Stock Analyst at Sidoti & Co.
(3.02)
# 1,430
Out of 5,008 analysts
9
Total ratings
60%
Success rate
71.66%
Average return
Main Sectors:
Stocks Rated by James Sidoti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Downgrades: Neutral | $27 → $28 | $26.72 | +4.79% | 3 | Aug 5, 2025 | |
| SRDX Surmodics | Downgrades: Neutral | $43 | $28.82 | +49.20% | 1 | May 29, 2024 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $5 | $0.37 | +1,234.04% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $38 → $34 | $86.79 | -60.82% | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | $61 | $9.10 | +570.33% | 2 | Jan 21, 2020 |
STAAR Surgical Company
Aug 5, 2025
Downgrades: Neutral
Price Target: $27 → $28
Current: $26.72
Upside: +4.79%
Surmodics
May 29, 2024
Downgrades: Neutral
Price Target: $43
Current: $28.82
Upside: +49.20%
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $5
Current: $0.37
Upside: +1,234.04%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: $38 → $34
Current: $86.79
Upside: -60.82%
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: $61
Current: $9.10
Upside: +570.33%